PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF
申请人:Rafestin-Oblin Marie-Edith
公开号:US20130203718A1
公开(公告)日:2013-08-08
The present invention relates to a compound of formula (I): for its use as progesterone receptor antagonist, in particular for its use for the prevention and/or the treatment of cancer or uterine pathologies.